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   Higher education is unquestionably one of the sectors 
where the UK can point to success on a global scale. 
The Russell Group represents institutions which are 
pioneering some of the most exciting and ground-
breaking research being conducted anywhere in 
the world.
   This report focuses on the beneﬁ  ts of university research 
to new and existing businesses, and shows how that 
research serves as a platform for economic growth in 
the UK. It demonstrates how Russell Group research 
has brought new knowledge and new perspectives to 
university-business partnerships, helping businesses to 
innovate. It has informed the education and training of 
highly-skilled graduates and postgraduates, giving them 
the qualities which will be needed by UK businesses 
to stay ahead of the competition. It has shaped the 
development of new products and services within UK 
industry, and helped to improve businesses’ strategy, 
management, and productivity.
   In some cases, often when least expected, research within 
Russell Group institutions has led to truly world-changing 
discoveries, offering the potential to revolutionise whole 
areas of healthcare, technologies, or our society. These 
breakthroughs have sometimes led to substantial revenues 
for universities and for the UK economy. A sample of such 
breakthroughs included in this report generated combined 
wealth of almost £2bn.
   This success owes much to investment by businesses 
themselves, and the UK’s unparalleled level of charitable 
investment in research has made a major contribution 
to the internationally leading work practised within its 
higher education institutions. Above all, however, the 
UK’s leadership in research has been founded upon 
public investment.
   This document, building on the activities, insight and 
experience of Russell Group institutions, shows that 
public investment in their research has resulted in 
far-reaching beneﬁ  ts which have been shared by the 
UK’s businesses, the government, and by the taxpayer. 
It demonstrates that investment in leading research is 
not a luxury, to be set to one side in times of increased 
stringency. Instead, it is an indispensible component 
of the UK’s economic competitiveness, and the key 
to its future growth.
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Higher education is unquestionably one of 
the sectors where the UK can point to success 
on a global scale. The Russell Group represents 
institutions which are pioneering some of the 
most exciting and ground-breaking research 
being conducted anywhere in the world. Over many years, the UK has built up a powerful 
research base, the excellence and productivity of 
which very few countries can match. A signifi  cant 
proportion of this national research base resides 
within the university sector and in the Russell Group 
universities in particular.
EXECUTIVE SUMMARY3
   This research excellence reﬂ  ects a strong tradition of 
research and development within UK industry, and the 
important work of the charities sector in supporting and 
funding research. However, it is underpinned by a strong 
commitment by government to public investment in 
science and research. Any government invests in research 
for its potential to have a positive impact on society, 
and as major beneﬁ  ciaries of public research funding, 
Russell Group institutions are committed to optimising 
the societal beneﬁ  ts of their research. One important 
aspect of this is beneﬁ  t to the economy.
   This report demonstrates the economic impact of research 
conducted within Russell Group universities. It focuses 
in particular on the beneﬁ  ts of university research to new 
and existing businesses. The full beneﬁ  ts of research are, 
however, much wider than direct economic impact and 
include beneﬁ  ts to health, quality of life and culture. 
   The case studies and data in this report demonstrate 
how businesses gain competitive advantage through 
collaborating with universities on research and 
research-based activities. Working with a university can 
enable a company, of any size or industry sector, to access 
the latest knowledge, ideas and research expertise relevant 
to its business. We present evidence of successful 
collaborations between university researchers and 
businesses, including long-term research collaborations, 
speciﬁ  c projects focused on near-market business 
problems, and research for improved business 
processes and efﬁ  ciency. 
   University research also plays a vitally important 
role in the development of the human capital that 
businesses need for success – “knowledge transfer 
on legs” as it has been called. Research-led teaching 
equips graduates with the personal and professional skills 
that employers need. Postgraduates in particular provide 
businesses with a highly-skilled and critically important 
labour force trained in the latest research developments 
and techniques, able to think creatively and solve complex 
problems. This report includes examples of universities 
and businesses working together to optimise the transfer 
of knowledge between academic research and the 
economy, through activities focused on graduates 
and postgraduates. 
   Many businesses access the research expertise 
of universities through consultancy aimed at 
addressing speciﬁ  c business problems. A signiﬁ  cant 
proportion of academics at Russell Group universities 
engage in consultancy with business and other external 
organisations. We present examples of how a wide range 
of different companies have gained practical beneﬁ  ts 
from the research expertise of universities through this 
form of engagement. Other examples demonstrate the 
role played by university research in supporting the 
provision of continuous professional development to 
businesses, and in attracting international investment 
in the UK from global research-intensive companies.
   A further very important way in which universities beneﬁ  t 
the economy is through the commercial exploitation 
of research through licences and spin-out companies. 
Russell Group universities have a strong track record 
in achieving economic impact through these processes. 
Based on new data from over 100 case studies collected 
from our institutions, the latter part of this report looks at 
how economic beneﬁ  t is generated from the commercial 
exploitation of research. 
   Our case studies show that signiﬁ  cant economic impact 
is derived from the commercialisation of research in a 
range of different subjects and disciplines, as well as 
multidisciplinary research. Moreover, professional 
knowledge transfer staff and processes within universities 
are critical in ensuring that research results in maximum 
beneﬁ  t to the economy. This is an area in which universities 
have invested signiﬁ  cantly in recent years, with good results.
   From our analysis of the Russell Group case studies 
on commercialisation, it is clear that a majority of highly 
successful licences and spin-out companies have emerged 
from long-term curiosity-driven research. Moreover, our 
analysis demonstrates that successful commercialisation 
requires sustained long-term investment in research, 
often over many years or even decades.
   In some of the commercialisation case studies presented 
here, the ﬁ  nancial returns have been quite spectacular. 
However, it would be misleading to consider the impact of 
technology transfer only through its direct and quantiﬁ  able 
economic impact. In many of the cases we have looked 
at we also found evidence of wider beneﬁ  ts to society 
resulting from the commercialisation of research.
   Whilst this report focuses on the beneﬁ  ts of research to 
businesses, research is also capable of much wider impacts 
on society, through positive effects on policy-making, 
healthcare, the environment, and other quality of life 
improvements. These wider impacts tend to be more 
difﬁ  cult to quantify than impacts on businesses. We will 
publish a subsequent report which will look at these 
wider impacts of research.
   World-class university research is an invaluable resource 
supporting the growth of new and existing knowledge-
intensive businesses in the UK and worldwide. This 
report demonstrates the important impact of research 
on developments in key sectors of the economy such as 
biotechnology, aerospace, pharmaceuticals, new energies 
and creative industries. It also demonstrates how research 
underpins the high-level skills and development of human 
capital which will be so crucial to the success of businesses 
in the future.INTRODUCTION 
  1.0 The Russell Group of Universities
   The UK research base is highly productive and has 
a global reputation for excellence: with just 1% of the 
world’s population, the UK earns 12% of international 
citations.1 
   The Russell Group of Universities represents the 20 
major research-intensive universities of the UK. These 
institutions are vibrant and dynamic organisations, actively 
contributing to their local communities and economies, 
yet inﬂ  uencing and achieving impact on a truly global 
scale. By virtue of their size and the quality of their 
research and teaching, Russell Group universities create 
and catalyse a hugely diverse range of economic activity 
which has a major impact on the economy of this country. 
   The size and scope of Russell Group universities makes 
them a prominent UK and international industry2 in their 
own right:
 –    they have a total economic output of £22.3bn per 
annum – equivalent to 40% of the total output for 
the sector
 –    they are responsible for supporting 243,000 jobs 
UK-wide – equivalent to 36% of jobs supported 
by the sector
 –    they are a major UK export industry, with overseas 
earnings of over £2bn per annum – 38% of total 
earnings for the sector.
   These institutions represent only 12% of the higher sector 
by number, but nevertheless account for a signiﬁ  cant 
proportion of the UK’s research base, employing 40% of 
academic staff, and educating 56% of PhD students within 
the higher education sector. Russell Group universities 
win the majority of the competitively available research 
funding from a wide range of sources. Approximately 
two thirds of research grants and contracts from external 
funders are won by Russell Group institutions, including 
63% of research grants and contracts from UK industry 
and commerce.3
   Figure 1 illustrates research income to Russell Group 
institutions as a proportion of the UK higher education 
sector totals. The majority of such funding is awarded 
on a competitive basis, in some cases in competition with 
other research institutions around the world. This success 
in competing for funding from multiple public, private and 
charitable funders reﬂ  ects the great breadth and depth 
of research excellence at these institutions.
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Figure 1: Investment in Russell Group research as proportion of HE sector total45
 2.0  Deﬁ  nition of economic impact
   This report focuses on the economic impact of the 
research undertaken within Russell Group universities. 
We deﬁ  ne economic impact as the effects of research 
on the long-term economic growth5 and the well-being of 
the nation, including the beneﬁ  ts to the following groups:
 –    businesses and other organisations, which beneﬁ  t from 
new and improved technologies and skills. Their increased 
productivity and enhanced ability to offer new goods and 
services in turn increases the nation’s output and GDP
 –    government, which beneﬁ  ts from increased knowledge 
to enhance policy making and achieve its desired 
outcomes
 –    the general population, which beneﬁ  ts from a better 
quality of life through consuming new goods and 
services, and improved policy making.
   The impacts on businesses and their ability to offer new 
goods and services tend to be more easily measured than 
those on policy and quality of life. For example, the value 
of a relatively new company can be a proxy measure for 
the market value of a new technology, which will in turn 
create new products and services, and contribute to a 
higher quality of life.
   This report focuses predominantly on the beneﬁ  ts to 
businesses. It explores the extent and nature of the 
interactions of Russell Group universities with business, 
and provides new evidence that demonstrates the market 
value of new technologies arising from research carried 
out at our institutions.
   However, the potential impact of research far exceeds 
the commercial world, and economic impact also derives 
from the effects of research on policy-making and society 
through better healthcare outcomes, improvements to the 
environment, and many cultural and quality of life beneﬁ  ts. 
Although many of the case studies in this report illustrate 
these wider impacts they tend to be more difﬁ  cult to 
quantify than impacts on businesses. This is because the 
effect of research on policy-making and society can be 
very wide-ranging in nature. We will publish a subsequent 
report which explores the impact of research on public 
policy and society more widely, including looking at 
partnerships with government departments and their 
agencies and the charitable sector.
   3.0 Demonstrating the economic impact of publicly 
funded research 
   Russell Group institutions are recognised internationally 
as leading research universities – a reputation that has 
been based on a sustained programme of public investment 
and high level political support for science and research. 
The Science and Innovation Investment Framework 
published in 2004 aimed to achieve a substantial overall 
increase in R&D investment in the UK, rising to 2.5% of 
GDP by 2014.6 As a result, public spending on science 
and research has risen steadily.
   Russell Group universities recognise that this signiﬁ  cant 
public investment needs to be justiﬁ  ed through evidence 
of successful translation of research into economic and 
social beneﬁ  ts for the nation. This report looks at a wide 
range of cases in which research has led to clear economic 
impact. It is worth noting that in the vast majority of 
these examples substantial economic beneﬁ  ts have been 
generated from “blue skies” or long-term curiosity-driven 
research projects. This illustrates the importance and 
value of public investment in research of this kind, as well 
as projects with more immediate economic potential. Public 
spending in the UK is entering a period of contraction. 
The research base needs to demonstrate that investment 
in science and research continues to be a priority area 
for public investment. In the current global downturn, the 
UK needs more than ever to support the businesses able 
to continue the growth of a knowledge economy.
   Case studies throughout this document illustrate the 
impact which research is having within areas of major 
economic potential. There are examples from aeronautical 
engineering, plastic electronics, biotechnology and 
pharmaceutical development, and low-carbon energy 
solutions. The case studies also highlight how research 
is enabling the development of new technologies and 
processes, to enhance business competitiveness and 
to improve the skills and capabilities of the workforce.  4.0 Structure of this report
   In Part 1 of the report we look at the range of different 
ways businesses and Russell Group universities work 
together to deliver economic impact, through the training 
and development of skilled graduates and researchers, 
via research collaborations, knowledge exchange and 
commercialisation of research, through contributions 
to workforce development, and by attracting inward 
investment to the UK.
   In Part 2 we present a new evidence base drawing 
on over a hundred case studies from Russell Group 
universities, which demonstrate economic impact through 
the commercialisation of research. The case studies 
highlight the economic impact of basic as well as more 
applied research, and illustrate the commercial potential 
of interdisciplinary research. We also consider the ways in 
which universities support the development of economic 
impact through commercialisation. Through the case 
studies we have also highlighted the typical timescales 
from research to economic impact and looked at some of 
the wider, non-commercial, beneﬁ  ts arising from commercial 
exploitation of research.
   Although we cannot quantify in detail the contribution that 
Russell Group universities’ research has made to the UK 
economy and society, the evidence provided in this report 
gives an insight into the very signiﬁ  cant returns which follow 
from the public investment in university research.
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Part 1
Business and Russell 
Group universities 
working together 
to achieve economic 
impact from researchPART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
   1.0 How university research beneﬁ  ts businesses
   World-class academic research underpins the success 
and competitiveness of many UK businesses. It has been 
well documented that companies, particularly knowledge-
intensive ones, gain competitive advantage from working 
with universities by:
   Access to research expertise. Leading researchers are 
a source of latest research ﬁ  ndings and thinking within the 
university, but also a source of knowledge about the latest 
developments nationally and globally.
    Access to resources. Businesses beneﬁ  t directly by access 
to publicly funded IP. Co-funding research with university 
partners also enables companies to access leading research 
talent and to lever public funding, to accelerate the 
development of an area of research and to pursue more 
research than the company would be able to afford by 
itself. There is also considerable evidence that public 
investment in R&D encourages private sector investment. 
A strong correlation exists between the volume of public 
investment in R&D and the volume of private investment 
in R&D, particularly in the biomedical sciences.7
   Access to interdisciplinary knowledge and expertise. 
Increasingly, new opportunities and innovations are likely 
to arise at the boundaries between traditional research 
disciplines. Companies are aware of these opportunities 
and also need to access and utilise the latest research 
knowledge and ﬁ  ndings in an interdisciplinary way. Larger 
research focused-universities are able to provide these 
kinds of joined-up solutions.
   Access to cutting-edge facilities. In certain areas of 
research, technologies and facilities are becoming so 
large, specialist and expensive that companies, particularly 
smaller or less research-intensive businesses, are unable 
to justify the capital investment.8 Universities often host 
such facilities and can provide access to businesses as 
well as to other resources such as data and collections.
   Research consortia. By partnering with universities, 
companies are able to collaborate with potential 
competitors and supply chain partners in early-stage, 
pre-competitive research.
   Proximity. Evidence shows a close association between 
the performance of R&D intensive ﬁ  rms and their proximity 
to centres of university research.9
   Human capital. Numerous studies have shown that 
businesses use the recruitment of graduates and research 
staff as a primary way to access the latest research 
and skills.
    Consultancy. Professional consultancy enables businesses 
to access knowledge, new approaches and skills from 
within the university sector and address speciﬁ  c business 
problems.
Case study 1
GSK Clinical Imaging Centre
Imperial College London
Key funding source: GlaxoSmithKline, Imperial 
College London, Medical Research Council
The GSK-sponsored clinical imaging centre at Imperial 
College London is a multi-million pound collaboration 
which has created a world-leading facility drawing on 
the research expertise of Imperial College.
GlaxoSmithKline committed to a £50m investment in 
the centre, which officially opened in 2007. Alongside 
parallel investment from Imperial College and the 
Medical Research Council, GSK’s commitment has 
equipped the centre with state of the art scanning 
and imaging facilities, which will enable scientists to 
improve their understanding of some of the world’s 
most serious diseases, including cancer, cardiovascular 
disease and neurological disorders. Through improving 
fundamental understanding of diseases, it will create 
a platform for the development of new, more effective, 
treatment and prevention.9
   Continuing professional development (CPD). 
Engaging with universities via collaborative projects, 
consultancy or other means enables employees to gain 
new skills, techniques and ideas, which can improve 
company productivity and performance.
   Businesses gain these beneﬁ  ts through a wide range of 
direct and indirect interactions with university research. In 
the following sections we explain how UK and international 
companies, both large and small, and Russell Group 
universities work together to deliver economic impact 
from research through:
 –    research collaboration
 –    human capital
 –    consultancy
  – continuing professional development.
   All of these activities ultimately help to boost the reputation 
of the UK as a location of choice for research and research 
partnership. Therefore, we will also provide evidence of how 
Russell Group universities have attracted inward investment 
from the private sector. 
   The new knowledge generated by excellent research may 
be used by companies to inform and improve their own R&D 
programmes, or stimulate the development of new goods 
or services. Equally, it may improve business productivity 
through improved technologies and manufacturing 
processes, shortening supply chains, improved business 
processes, management or organisational change. 
Mansﬁ  eld et al ﬁ  nd that 10% of all new products and 
services developed by companies surveyed could not 
have been developed, without signiﬁ  cant delay, without 
university research.10
   A recent study, undertaken by the Advanced Institute of 
Manufacturing (AIM) for the EPSRC, looked at motivations 
for commercial engagement with academic research. The 
report found that access to fundamental understanding 
and research expertise is one of the most important 
motivations for industrial collaborators engaging with 
universities. Amongst surveyed companies, the most 
frequently cited reason for collaboration with universities 
was “access to state of the art thinking in science 
and technology”. 57% of companies rated this as a “very 
important” or “crucial” factor motivating engagement. 
The ability of universities to undertake exploratory 
research was the sixth most frequently cited reason 
for collaboration, with 30% of companies citing this 
as important or crucial.11
Case study 2
Great Western Research
The University of Bristol
A collaboration between the University of Bristol, 
the universities of Bath and Exeter, and the aerospace 
manufacturer Airbus UK, is pioneering the development 
of lighter and stronger aircraft, as well as investing 
in basic academic research and skills.
The University of Bristol is closely involved in 
the organisation Great Western Research, which 
orchestrates research collaborations between business 
and higher education. One project coordinated by 
Great Western Research is exploring the potential 
of “smart materials” – materials which can radically 
change shape in an electric field. The research involves 
a partnership between Bristol and the universities of 
Bath and Exeter, with funding from Airbus UK jointly 
supporting eight PhD studentships. 
The research may have long-term technological 
potential, with the possibility of faster and more 
efficient flights, but investigations are at an early 
stage. Much of the research involves fundamental 
“blue sky” investigations into the properties of exciting 
new materials.
Martyn Cantrell, composites engineer and project 
manager with Airbus for GWR, explained “As it’s very 
blue sky, in terms of potential and products to take 
to the market, that’s not what we are expecting. 
It's about the idea.”PART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
   Russell Group universities offer all of these opportunities 
and resources to the private sector, and seek to work in 
partnership with businesses both large and small to deliver 
economic impact. A concentration of excellence in terms 
of researchers, postgraduates, facilities and interdisciplinary 
expertise coupled with increasing investment in knowledge 
transfer processes and more ﬂ  exible processes for 
engagement, means that many Russell Group universities 
are well placed to continue to work in partnership with 
business to boost the economic competitiveness of the UK.
   We are building from a strong base. Data from the 2009 
Higher Education Business and Community Interaction 
Survey show that Russell Group universities are actively 
engaged in a broad range of partnerships, collaborations 
and relationships with business and industry, to maximise 
the potential impact of their research on the economy. 
  In 2007-08 Russell Group universities:
 –    secured a total of £244m from the commercial sector 
for contract research, 66.2% of the total across the UK 
HE sector
 –    of this, £229m came from larger companies (68.9% 
by value of the sector total) and £15m from SMEs 
(41.1% by value of the sector total)
 –    accounted for 16 of the top 20 recipients of income 
for contract research from large companies, and 12 
of the top 20 recipients of income from SMEs.
   Of course income from research contracts is only a part 
of the picture. Over the last ﬁ  ve years, knowledge transfer 
revenue at Russell Group universities has increased 
across a broad range of income streams (Figure 2).
   A content analysis of 16 Russell Group universities’ 
strategies for the use of HEIF4 funding showed that, in 
addition to supporting licensing and spin-out formation:
 –    11 were also focused on developing or supporting 
business partnerships
 –    eight were speciﬁ  cally focused on supporting 
collaborative research.
  2.0 Research collaboration
   Russell Group universities and businesses work together 
on research in many varied ways including via the 
co-funding, co-design and/or co-production of research, 
joint research centres, joint chairs and other appointments 
and research contracts. Such partnerships may be built 
upon bilateral or multilateral relationships and may involve 
one or more universities and one or more businesses. They 
may be short-term and focused on a speciﬁ  c project or 
piece of research or more strategic, involving a long-term 
commitment between the university and the company 
to work together on basic research.
   Ultimately the goal of most such collaborations is 
to develop intellectual property (IP) with commercial 
potential, now or in the future. Part 2 of this report 
addresses in detail how research from Russell Group 
universities has been exploited for commercial beneﬁ  t 
via licences, patents and spin-out companies.
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Case study 3
Innovation in financial services
University of Oxford
Key funding source: Man Group plc
The Oxford Man Institute of Quantitative Finance was 
opened in September 2007. The institute has been 
established on a model of academic excellence, 
co-existing with a culture of innovation and commercial 
engagement in the finance sector. 
The result has been the securing of a long-term 
partnership with Man Group (the world’s largest 
provider of hedge funds), with benefits for both 
parties: the arrangement will leverage significant 
commercial investment for the university, while offering 
its partner direct access to its research and expertise. 
Man Group has committed to fund the Institute with 
a core research grant of £10.45m, and Man Group 
executives will be seconded to the “laboratory” to 
pursue research projects of their choosing in relation 
to quantitative finance. In addition, Man Group is 
funding an endowed chair of quantitative finance. 
A framework contract has also been agreed under 
which academics across the University may provide 
consultancy in order to further Man’s objective of 
providing innovative products and tailor-made solutions 
to private and institutional investors.
According to Neil Shephard, Research Director of 
the Mann Laboratory at the institute:
“Innovative quantitative research is the lifeblood of 
our industry, and if you want your staff to be genuinely 
creative then you have to provide them with a 
stimulating research environment.”
Case study 4
The Environmentally-friendly 
Engine (EFE) project
Universities of Birmingham, Cambridge, 
Sheffield and Queen’s University Belfast 
Key funding source: Technology Strategy Board, 
Rolls Royce plc
The EFE brings together a consortium of industry 
representatives and major research-intensive universities 
with the aim of delivering significant improvements 
in air travel efficiency and environmental impact. 
Led by Rolls Royce in collaboration with four other 
industry partners, the project involves the Universities 
of Birmingham, Cambridge, Oxford, Sheffield, 
Loughborough and Queen’s University Belfast.
The programme began on 1 January 2006 and will 
run until January 2010, at a total cost of £95m.
As part of a national aerospace strategy for the UK, 
the project will deliver on environmental goals set for 
2020 by the Advisory Council for Aeronautics Research 
in Europe (ACARE). It will develop new technologies 
across a broad spectrum of investigation, from basic 
research to technology validation. In doing so, it will 
enhance the UK’s competitiveness in key aeronautical 
technologies such as high efficiency turbines, low 
emission combustion and engine control.PART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
   2.1 Long-term strategic research partnerships
   Knowledge-intensive and high-tech businesses 
form strategic, medium to long-term relationships 
with universities with a focus as much upon enhancing 
fundamental understanding as working towards a 
speciﬁ  c commercial application. It is typically larger 
companies and multinationals in R&D intensive sectors 
such as pharmaceuticals and aerospace which have 
been amongst the foremost investors in these kinds 
of academic research collaborations in the UK.
   Russell Group universities have a strong track record 
of working in partnerships with businesses on research 
which would generally be regarded as fundamental in 
nature, and where the business partner can recognise 
long-term potential to address its own needs. Case 
studies 1 and 2 provide good examples, looking at 
GlaxoSmithKline’s investment in a Clinical Imaging 
Centre at Imperial College and a partnership between 
the University of Bristol and Airbus UK conducting 
fundamental research into the properties of aerospace 
materials.
   A number of major companies have co-located their 
research laboratories or research staff alongside leading 
university departments to ensure that their researchers 
are able to work closely with academics pursuing more 
fundamental research goals. Access to state of the art 
research equipment and facilities is also another motivating 
factor. This is exempliﬁ  ed by Toshiba and Microsoft, both 
of whom have invested in major research laboratories 
within departments of University of Cambridge.12 According 
to the CIHE, a primary motivation for Toshiba embedding 
research facilities within University of Cambridge was 
to afford its researchers access to the university’s 
sophisticated equipment to explore the fundamental 
properties of materials.13
   The UK derives signiﬁ  cant economic beneﬁ  t from this 
co-location of leading industries alongside centres of 
research excellence. It is a model which has been adopted 
not only by manufacturing companies in the science 
and technology ﬁ  elds, but also by innovative companies 
in the service sector (See case study 3), and research 
has highlighted its importance in generating clusters 
of innovation worldwide.14 The EU has also sought to 
stimulate similar centres of research and innovation through 
its investment in knowledge innovation clusters (KICs).
Case study 5
Centre for Materials Discovery
University of Liverpool
Key funding source: NWDA, ERDF, Industry, 
university own funds (including HEIF)
The Centre for Materials Discovery (CMD), based at 
the University of Liverpool, provides a research centre 
and a research and knowledge transfer service to 
academia and industry in the area of high throughput 
materials discovery. 
Building on the strong base of academic expertise 
within Liverpool, and working closely with other 
universities in the North-West, the centre aims to 
support businesses by providing access to leading 
research, training for industry personnel, and world-
class facilities such as robotics and advanced ICT.
The Centre is explicitly targeted at the use of research 
excellence to support business endeavour, particularly 
businesses based within the Northwest. Figures 
provided by the university indicate that, after three 
years, the centre has had a major impact within the 
Merseyside region, including:
– 245 Merseyside net jobs created
– 65 NW businesses received advice
– 27 Merseyside SMEs receiving assistance
– more than 70 individuals trained in “High Throughput” 
   techniques 
– £5.85m Net Value Added to the Merseyside region.13
   2.2 Research to address more speciﬁ  c and 
near-market business problems
   A considerable proportion of university-business research 
collaboration is concerned with helping companies to ﬁ  nd 
new ways of addressing challenges which are nearer to 
market . The AIM/EPSRC study emphasises that access 
to the problem-solving capability of expert academic 
researchers is a key priority for many companies both 
large and small. 
   Case studies 4 and 5 provide good examples of this 
kind of activity at Russell Group universities. They also 
demonstrate how universities have been successful 
in collaborating with one another, in order to meet the 
needs of businesses.
   2.3 Research for improved business processes 
and efﬁ  ciency
   As well as technological solutions, businesses also look 
to leading universities for new research and thinking on 
leadership, management and organisational development. 
Research in business management, ﬁ  nance and related 
subjects can help to improve business models and 
contribute to the development of more efﬁ  cient business 
management (eg more effective marketing strategies).
   Case study 6 highlights the work of the University of 
Liverpool in bringing its management and marketing 
expertise to local businesses in particular, through its 
Agility Centre. Later, we will consider an example of how 
university-business collaboration on research has provided 
consultancy and skills developments which helped to 
improve sales and customer services (case study 15).
Case study 6
Agile Marketing
The University of Liverpool
The Agility Centre at the University of Liverpool has 
been established to help local businesses, particularly 
SMEs, develop flexible marketing and strategic 
approaches to a changing business environment. 
Building on research expertise developed initially 
within the Department of Engineering at the University, 
the centre is able to offer a range of assistance to 
companies in the region; from consultancy with its 
expert business analysts, to arranging work placements 
with graduates and final year undergraduates.
One local SME which has benefited from the research 
expertise at the centre is Newton Instruments, a 
manufacturer of instrumentation and measurement 
equipment for major multinational companies such 
as UniLever.
Newton turned to the Agility Centre for assistance 
in developing its marketing strategy and updating its 
website. The expertise at the centre helped Newton 
develop a more focussed marketing strategy and to 
develop its website as a front-line marketing tool. 
According to Newton’s Chief Executive:
“… the Agility Centre has been a tremendous help. 
It was like having my own marketing mentor.”PART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
   2.4 Research collaboration with SMEs
   The AIM/EPSRC survey found that “access to state of the 
art thinking” is the most important factor overall in driving 
research collaboration amongst SMEs as well as larger 
businesses.
   Whilst Russell Group universities collaborate with 
most of the world’s leading multinational companies and 
leading British industry, they also have a strong record 
of engagement with SMEs. The 2009 HEBCI survey 
showed that:15
 –    19 out of 20 Russell Group institutions have established 
a dedicated unit or enquiry point for SMEs
 –    18 of 20 have the capacity to assist SMEs in specifying 
their needs
 –    Russell Group universities secured £15m in research 
contracts from SMEs (41.1% by value of the sector total).
   Case study 7 describes a typical example of university-
SME research collaboration, facilitated via a Knowledge 
Transfer Partnership (KTP).
   3.0 Human capital
   Russell Group universities make a major contribution to 
the UK economy through the training and development of 
graduates and researchers with the skills that businesses 
need to succeed. This includes those who will go on to be 
managers and business leaders, as well as researchers, 
engineers, technical and other specialists.
   The knowledge that graduates and postgraduates bring 
to the workplace is recognised to be one of the most 
important pathways through which research exerts 
inﬂ  uence and impacts upon the economy.16 The training 
of skilled graduates is one of the principal beneﬁ  ts of 
research – facilitating transfer not only of a knowledge 
base informed by the latest scientiﬁ  c developments, 
but also a familiarity with the most up-to-date scientiﬁ  c 
techniques, a capacity for creative thinking and ability 
to solve complex problems.17
   Russell Group universities are committed to equipping 
their students with the personal and professional skills 
that employers are looking for in an increasingly 
knowledge-based economy. This is fostered through 
distinctive research-led teaching which encourages a 
culture of enquiry-based, independent learning in a 
world-class environment. Research-led learning actively 
engages students in their learning experience, 
encouraging them to pursue new knowledge and to 
develop independence of thought, critical thinking, 
entrepreneurial skills and the ability to handle a wide 
range of challenges.
Case study 7
Improving management within a local SME
University of Warwick
The skills and expertise developed by one student 
at the University of Warwick business school have 
helped to rejuvenate the management techniques and 
company culture within a local manufacturing SME.
Strip Tinning Ltd (STL) is a Birmingham-based SME 
which manufactures components for the automotive, 
communication and construction industries. It turned 
to the research expertise within the University of 
Warwick business school in order to review and 
re-develop its strategic management processes 
and help change company culture.
Through a knowledge transfer partnership, STL were 
able to gain direct benefit from the research-informed 
skills of Susanne Tanner, who was carrying out an 
MSc at the Business School. Working closely with 
Dr Charles Tennant, the lead academic from the 
University, Susanne was able to employ research 
techniques developed within the business school 
to identify an appropriate management process 
for the company. She recommended the a Western 
adaptation of a Japanese management technique, 
“Hoshin Kanri” would help meet the company’s goals.
The partnership helped introduce improved management 
techniques, more effective reviewing and assessment 
of progress, and an improved company culture which 
has made a real impact on performance. 15
A project undertaken by a KTP associate from 
Queen’s University provided a manufacturing company 
with a major competitive advantage and improvements 
to customer satisfaction and confidence.  
Macrete Ireland Ltd is an independent precast 
concrete manufacturer based in Co Antrim with over 
30 years’ experience in the design and manufacture 
of a wide range of concrete products and systems.  
Steel reinforcement in concrete bridges tends to 
corrode with time undermining the structural integrity 
and recent changes in European legislation have 
necessitated the replacement of relatively modern 
bridges to meet new load-carrying criteria.  
Macrete recognised the market potential in developing 
a new unreinforced bridge arch utilising a non-corrodible 
polymer. However, it also recognised the complexity of 
this task. Successful product development demanded 
cost analysis, advanced material development, numerical 
analysis and field testing alongside resource and staff 
management.  
Macrete entered into a KTP in collaboration with the 
School of Planning, Architecture and Civil Engineering 
at Queen’s University Belfast. The KTP Associate, 
engineer Abhey Gupta, worked with Macrete to 
successfully develop a unique, cost-effective, highly 
durable and aesthetic concrete block arch system.  
The project provided Macrete with a major advantage 
in the bridge market.
 
Case study 8
Improving the market position of a 
manufacturing company
Queen’s University Belfast
Case study 9
A statistical methodology for asset surveys
Newcastle University
Newcastle University’s Industrial Statistics Research 
Unit (ISRU) has been delivering consulting, learning 
programmes, coaching, and research services since 
1984 and has worked extensively with the National Grid.  
One project was to determine sample size and sample 
selection methodology for a major survey of National 
Grid’s assets. After reviewing data availability, the work 
involved sample size calculations and advising on 
methodology for selecting a random, representative 
sample which would give precise estimates efficiently. 
A well-constructed questionnaire and measurement 
protocol were developed and thorough follow up 
ensured a very high response rate. After assuring the 
quality of the data, estimates of asset properties were 
obtained. In addition, extensive statistical analysis was 
carried out to look for relationships between different 
aspects of the data. 
The statistical analysis helped National Grid to improve 
its understanding of the performance of its assets.PART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
   There is clear evidence that employers value this kind 
of research-led education: 
 –    a study of graduates from ‘research-intensive’ 
universities, including universities from the Russell 
Group, indicated a wage premium over other graduates. 
Almost half of all graduates from research-intensive 
institutions were found to be earning £25,000 or more 
3½ years after graduation, compared with just 29% 
of graduates from ‘other HEIs’18
 –    six months after graduation, Russell Group graduates 
can expect an average salary premium of more than 
£3,500 over graduates from the rest of the sector19
 –    Russell Group graduates are rated amongst the best 
in the world by employers. Five of them featured in the 
top ten institutions in the world in a major survey of 
graduate recruiters, and a total of 13 of them featured 
in the top 50.20
   A substantial proportion of undergraduate programmes at 
Russell Group universities already offer students internships 
with leading companies and other employers in the UK 
and overseas, and many also provide opportunities for 
participation in real life projects and problem solving 
particularly during the ﬁ  nal year of study.
   Russell Group universities host more than half of the UK’s 
PhD students. They host 60% of students supported by 
CASE studentships. This is where the student is co-funded 
by a business, government or charitable partner, and spends 
a proportion of their time working on a project within the 
workplace.21 Russell Group universities also aim to provide 
all PhD students with training in transferrable skills as a 
core part of their doctoral degree.
   Run by the Technology Strategy Board, Knowledge Transfer 
Partnerships (KTPs) co-fund graduates and postgraduate 
to work on solving technical or business problems within 
a company or public sector organisation. The aim of the 
initiative is to help businesses and organisations access 
skills and expertise from within the university sector to 
help improve their productivity and performance. Russell 
Group universities are the academic partners on 215 
current awards (almost 25% of the total), supervising 
students and researchers working in a huge range of 
organisations from big pharmaceutical and aerospace 
companies, to construction, engineering, IT, telecoms, 
utility, and healthcare companies of all sizes as well 
as local authorities and the NHS. 
   Case study 8 from Queen’s University Belfast is one 
example of how KTP projects can enable businesses to 
beneﬁ  t from the high-level skills of university associates, 
and gain access to knowledge and facilities of university 
research departments. 
Case study 10
Increasing commercial understanding of 
intellectual property rights regimes
London School of Economics & Political Science 
A world-leading pharmaceutical company approached 
LSE to commission research and consultancy into 
developing a better understanding of the international 
intellectual property rights regime, and to conduct 
a comparative study of two specific countries.
LSE Consulting put together an expert team of 
academics and coordinated both the knowledge- 
creation and knowledge-dissemination stages of 
the project. Two groups of experts conducted field 
research, interviews and data collection in the two 
countries assigned. The findings were analysed and 
compiled into a comprehensive report for the client. 
The dissemination stage of the project culminated 
in a workshop held at the LSE, which was attended 
by the client, specialist academic consultants and 
distinguished academic experts, and public sector 
officials working in the field. 
LSE’s expert team delivered much more than just a 
research and consultancy project. The team achieved 
for the client their objective of raising overall 
awareness of international intellectual property rights. 
Their analysis of the application of specific laws 
in selected countries directly informed discussions 
regarding the ways in which these might influence 
the ongoing and future operations of the client.17
 4.0  Consultancy 
   Consultancy is a very important way in which universities 
work with business to realise practical beneﬁ  ts from 
research, and to enhance business performance. A recent 
survey found that 40% of academics at Russell Group 
institutions had engaged in consultancy services with 
external organisations in the last three years.22 Moreover 
consultancy is not limited to academics in the engineering 
and physical sciences, but is also frequently carried out 
by researchers in the social sciences and the arts and 
humanities. 
   19 out of 20 Russell Group institutions use a 
commercialisation company or have a department 
within their institution to manage consultancies and 
commercial interactions. The inﬂ  uence of such support 
mechanisms is considerable in enabling the research 
expertise of our institutions to be communicated to a 
wider business audience. For example, Oxford University 
Consulting has a dedicated staff of seven. Its UK and 
international client base includes Astra Zeneca, Microsoft, 
the National Audit Ofﬁ  ce and the UN Development 
Programme. Many Russell Group academics have 
formed their own consultancy companies to externalise 
their research. A survey of over 8,000 Russell Group 
academics found that 13.1% had formed or run 
a consultancy company based on their research.23
   Case studies 9, 10 and 11 demonstrate how businesses 
have worked with universities to meet business challenges 
and gain practical beneﬁ  ts from research expertise through 
consultancy services.
Case study 11
Advice on flow splitters for the oil industry
University of Nottingham
Professor Azzopardi from University of Nottingham’s 
School of Chemical and Environmental Engineering 
provided consultancy services to Statoil, a Norwegian 
oil and gas company which ranks as one of the world’s 
largest oil traders.  
Statoil needed advice on a planned project to divide 
oil and gas mixtures gathered from North Sea wells 
to two separate destinations. Professor Azzopardi 
is one of the few experts in the world dealing with 
flow splitters in the oil industry. As the flow splitter 
is designed to be placed right at the bottom of the 
seabed, it is vital to get it right first time, because 
replacing it is a very difficult task. He used his 
experience to analyse the plans for the flow splitter 
Statoil was hoping to implement, carrying out 
calculations to support his assessment, based on 
the results of his own experiments and the published 
engineering literature.  
On the basis of Prof Azzopardi’s advice Statoil 
installed its new splitter into the North Seas in 
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Case study 12
The Climate Leadership programme
University of Cambridge
Key funding source: Industry-funded fees
Established with the input of former US 
Vice-President Al Gore, the Climate Leadership 
programme at the University of Cambridge aims to 
educate business leaders about climate change, and 
the risks and opportunities associated with mitigating 
its effects through their business practices. The 
programme draws on the research and expertise of 
senior University of Cambridge academics, as well as 
a number of external contributors. 75 delegates from 
businesses based within 17 different countries have 
so far attended the course, with the potential for 
significant benefits through the implementation 
of climate change mitigation strategies across 
UK and international businesses.
   5.0 Continuing professional development 
   Universities have an important role to play in helping 
adults re-train or improve their skills to enable career 
progression or a change in career. Whilst this report 
does not attempt to address this skills agenda per se, 
it is worth exploring how research can inform continuing 
professional development (CPD) activities.
   Engaging with universities, via collaborative projects, 
consultancy or other means enables company employees 
to work alongside researchers learning the latest skills 
and techniques which can improve their company’s own 
research activities. In turn this can also help a business 
to develop its “absorptive capacity” to enable it to take 
advantage of new products or processes developed 
in the future.
   In addition, Russell Group universities offer CPD as part 
of their portfolio of consultancy services. For example, 
professional development training offered by the Climate 
Leadership Programme at Cambridge, is a core means 
by which the expertise of this leading environmental 
research hub is disseminated to a wider audience 
(case study 12).
   Case studies 12–15 from the universities of Cambridge, 
Newcastle, Leeds and Southampton all illustrate a number 
of different ways in which research informs CPD.19
Case study 13
Biopharmaceutical processing 
Newcastle University
Key funding source: EPSRC; pharmaceutical 
industry funders 
The Newcastle University Research Centre 
in Biopharmaceutical Processing is a UK leader 
in developing techniques for drug development 
and production processes. The centre facilitates 
interdisciplinary research collaborations between 
biological, physical and engineering scientists; 
developing research expertise which is relevant 
to the problems and needs of industry.
The work of the research centre in collaboration with 
industry spans a broad range of knowledge transfer 
activities. Experts at the centre offer consultancy 
services and continuing professional development 
(CPD) courses to the pharmaceutical and biotech 
industries, such as the application of Process Analytical 
Technologies (PAT) for the pharmaceutical sector. 
Researchers at the centre also have long-term research 
partnerships with industry: Professor Gary Montague, 
Director of the centre, works closely with some of the 
UK’s leading pharmaceutical companies through a 
consortium called Britest. Britest has been established 
as a forum for supporting strategic research 
collaborations between industry and academia, aimed 
at developing innovative approaches to drug processing 
and manufacturing. 
Thus the centre exploits a range of knowledge transfer 
mechanisms both to underpin its research programme, 
and to achieve economic impact from that research 
by offering a competitive edge to its industry partners.
Case study 14
Community policing in the US
University of Leeds 
The research expertise of a University of Leeds 
academic has helped to advise and inform new 
approaches to community policing within the 
second largest city in the US.
Lieutenant Mark Stainbrock, a veteran from the Los 
Angeles Police Department, came to West Yorkshire 
on a six-month Fulbright Police Research Fellowship 
in 2007 to study British community policing and 
to benefit from the expertise of University of Leeds 
academics.
The research of Lieutenant Stainbrook, who has 
received over 50 commendations, was overseen 
by theology and religious studies lecturer Dr Alistair 
McFadyen of the University of Leeds, who also serves 
as a special constable for West Yorkshire Police. His 
research saw Stainbrook going on patrol with officers 
from Stainbeck Police Station, meeting with leaders 
of the Central Jamia Mosque and holding workshops.
Through his research, Stainbrook returned to the 
States with a toolkit of practical ideas for police 
officers, most of whom, according to Stainbrook, 
had a limited understanding of Islam or the 
“big picture issues”.PART 1 – BUSINESS AND RUSSELL GROUP UNIVERSITIES WORKING TOGETHER
Case study 15
From research to skills in marine engineering
University of Southampton
The Institute of Sound and Vibration Research (ISVR) 
at the University of Southampton, has developed a 
productive strategic partnership with Halyard – a 
manufacturer of marine exhaust systems – which 
spans research, consultancy and skills development.
Halyard specialises in noise reduction systems for 
boats and yachts. In 2003, responding to new EU 
regulations limiting the permissible noise generation 
on leisure craft, the company initiated a research 
project to investigate the key elements of noise 
generation on boats. The project was co-funded by 
the EU, and led to a fruitful research collaboration 
with the ISVR at Southampton.
The research identified marine exhaust systems as 
being the key problem and led to the development 
of a novel noise measurement device, which allowed 
Halyard to gain an advantage over its industry rivals.
Halyard approached the ISVR about developing 
a bespoke course for staff on noise and vibration 
awareness for its sales and development staff which 
has been hugely beneficial for Halyard: staff are 
able to apply technical expertise to an early stage 
in the design process, and customer satisfaction 
has improved, with clients evidently impressed by the 
technical knowledge of Halyard staff. The company 
was recently rated 9.3 out of 10 for customer 
satisfaction in this area.
Case study 16
Wyeth Early Clinical Development Centre
King’s College London
The world-leading quality of biomedical research at 
King’s and its NHS partner Guy’s and St Thomas’ 
hospital has been recognised through the award of 
Biomedical Research Centre status by the National 
Institute of Health Research (NIHR). The Wyeth Early 
Clinical Development Centre at King’s was established 
in April 2007. The Centre, established in collaboration 
with King’s partner NHS trusts, aims to accelerate 
the progress of clinical trials and facilitate the 
establishment phase. It is based within the NIHR 
Biomedical Research Centre (BRC) and employs 
monitoring staff at the Joint Clinical Trials Office 
(JCTO), which is operated between the College 
and the hospital.
The Early Clinical Development Centre at King’s 
is the only such centre in Western Europe.
The Centre is expected to leverage significant 
research investment from Wyeth over the next few 
years, and will be a fulcrum for new clinical studies, 
many of which will be first-into-man trials of new 
compounds.
As well as this substantial investment from Wyeth, 
King’s College’s world-class reputation for biomedical 
research, cemented by the award of Biomedical 
Research Centre, has also led to significant research 
investment by other major pharmaceutical companies 
such as GSK and Pfizer. 21
   6.0 Attracting inward investment
   The concentration of highly skilled and talented 
researchers in Russell Group universities, coupled with 
cutting-edge facilities and resources, plays a signiﬁ  cant 
role in attracting international R&D investment to the UK, 
particularly from research-intensive businesses. Inward 
ﬂ  ows of investment are important in stimulating further 
innovation, as globally competitive ﬁ  rms and universities 
tend to be better able to access the global knowledge 
stock and the latest technological advances occurring 
worldwide. Abramovsky et al (2006)24 found that there 
was a strong correlation between the presence of 
world-class academic research groups and location 
of commercial R&D investment; a correlation that was 
particularly notable for the pharmaceutical industry, 
and for foreign-owned businesses.
   The UK has been highly successful in attracting commercial 
investment in R&D from overseas. According to a 2005 
UN Conference on Trade and Development (UNCTAD) 
report, 45% of the UK’s commercial R&D spending 
derived from afﬁ  liates of overseas-based companies – 
proportionately more than the US, Japan and the majority 
of European countries. The UK was found to be the 
second most popular destination for international 
outsourcing of commercial R&D after the US.25
   Russell Group universities have more than doubled the 
research investment they receive from overseas sources 
since 2001.26 £75m (40%) of this investment derives 
from commercial sources. Case studies 16 to 19 highlight 
the success of Russell Group universities in attracting 
inward R&D investment.
   A strong reputation for research is also a major factor in 
attracting the large numbers of international students who 
study at British universities, bringing important investment 
to the UK through the fees they pay and their living 
expenditure.27 A recent UNESCO research paper 
found that the perceived academic excellence of host 
institutions was a key determinant of cross border student 
ﬂ  ow, and that “one can ﬁ  nd a positive association between 
the global ranking of universities and the preferred 
destinations of students”.28 Some international students 
choose to stay and work in the UK after their studies, 
and therefore continue to contribute to the economy. 
The growing international population with experience of 
study in the UK provides a valuable asset to the UK in 
terms of international trade and investment. For example, 
Tesco has said that its operations in Asia have frequently 
beneﬁ  ted from the goodwill towards the UK amongst 
Asians who have graduated from UK universities.29
Case study 17
Ultrafast Systems
University of Glasgow
Key funding source: US semiconductor research 
corporation; EPSRC, SFC, EU Commission
The Ultrafast Systems Group at Glasgow University is 
one of the world leaders in compound semiconductor 
transistor technology. The group’s internationally- 
renowned expertise has seen it secure research 
funding from a variety of sources, both domestic 
and international, including government departments, 
research councils and business.
In 2007 the group entered into a £1.2m partnership 
with the US Semiconductor Research Corporation 
(SRC), a consortium of multinational electronics 
companies including IBM, Hewlett-Packard and 
Intel. Building on research funded by the EPSRC, 
the Scottish Funding Council and the European 
Commission, the three year project seeks to replace 
existing silicon chips. By increasing the speed of 
processing, the new chips will speed up computers, 
enhance the battery life of mobile phones and digital 
cameras and improve the graphics in computer games.  
These advances could be available to manufacturers 
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Case study 18
UK-Pfizer stem cell collaboration
University College London
The UK’s global leadership in stem cell research is 
a factor not only of cutting-edge biomedical research 
within Russell Group institutions, but also of their 
pre-eminence in social sciences, ethics and philosophy 
research, which has helped to contribute to the 
permissive legislative environment surrounding 
stem cell research which exists in the UK.
The UK was the first country in the world to introduce 
permissive legislation for stem cell research, and 
Russell Group universities were quick to capitalise, 
allowing them to make a series of breakthroughs.
The UK’s leading position is a key factor in attracting 
investment from multinational corporations interested 
in the treatment potential which stem cell research 
offers. 
Professor Pete Coffey and his team at University 
College London are pioneering a technique 
which uses stem cells to treat age-related macular 
degeneration – a principal cause of blindness. The 
team’s expertise has attracted major investment from 
the world’s largest pharmaceutical company, Pfizer, 
who will sponsor a programme of research within 
the university which will accelerate the process of 
investigating stem-cell based therapies. In addition 
to funding, Pfizer’s involvement will provide the 
regulatory and clinical management expertise to 
allow treatments to be tested in a clinical setting.
Case study 19
Leica Geosystems
The University of Nottingham
The University of Nottingham has acknowledged 
international expertise in the field of global navigation 
research, including its Institute for Engineering Survey 
and Space Geodesy research and the Centre for 
Geospatial Science. The university and the East 
Midlands Development Agency built on this expertise 
with a £9m project to establish a new state-of-the-art 
Global Navigation Satellite Systems research facility 
on the University of Nottingham Innovation Park.
The project achieved early success when Leica 
Geosystems, a leading international company with 
sites in the US, Canada, Europe and Asia, decided 
to invest in a new research facility in close proximity 
to the university. 
Mark Concannon, president of Leica Geosystems 
Machine control division, commented “Our long 
association with the University of Nottingham, 
along with the ability to carry out GNSS testing on 
construction machines in a controlled environment, 
made the decision to locate in the East Midlands 
both logical and appealing”.
After an initial investment which led to ten new jobs 
in the region, Leica are now working closely with the 
university on developing systems which will enable 
dynamic positioning of machines and equipment within 
agriculture, mining and construction. The new systems 
will help improve efficiency by improving work flow 
between different market segments.23
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 1.0  Introduction
   In this section of the report we demonstrate the diversity 
and breadth of impacts from the commercial exploitation 
of excellent research undertaken in Russell Group 
universities.
   We ﬁ rst present an overview of the track record of 
Russell Group universities in the commercial exploitation of 
research, as demonstrated by the 2009 Higher Education 
Business and Community Interaction Survey (HEBCI) and 
our own survey of Russell Group institutions. We explain 
how universities work with business and industry, and 
utilise knowledge transfer professionals to facilitate 
and support the commercial exploitation of IP. 
   The case studies used throughout this section of the 
report are from a new survey of Russell Group universities 
undertaken in 2008 to identify successful examples of the 
commercial exploitation of research through IP licensing, 
patents, spins-outs, and co-production of research with 
potential users. This exercise collected 125 case studies, 
which have been analysed as far as practicable to explore 
the nature of the underpinning research, the inﬂ  uence of 
university knowledge transfer professionals and funding 
on successful commercialisation, the timescales involved 
in commercialisation, and the revenue generated. The 
methodology used is set out in Annex A.
  The case studies illustrate:
 –    the economic impact from basic research
 –    the need for sustained long-term investment in research 
and development to realise commercial potential
 –    the wider beneﬁ  ts and impacts arising from 
commercialisation.
   2.0 Overview of the commercial exploitation 
of research from Russell Group universities
   2.1 Some key statistics 
   Russell Group universities are effective and successful 
in the commercial exploitation of their research. A sample 
of ten Russell Group universities showed that all but one 
had higher overall venturing efﬁ  ciency than two major 
research-led US institutions chosen by the study.30 
Moreover, a recent survey of academics conﬁ  rmed that 
academics within Russell Group institutions are more 
likely to have taken out a patent, licensed their research 
to a company or formed a spin-out than academics 
at other UK institutions.31
   This performance is backed up by information from the 
2009 HEBCI survey (for 2007–08) which shows that:
 –    whilst the 20 Russell Group universities comprise 
12.5% of the UK’s HEIs, they recorded 64% of 
the total HE sector income from IP in 2007–08
 –    the total estimated annual turnover from companies 
spun out from Russell Group was £724m, 70% of 
the total for the whole of the HE sector
 –    active spin-outs from Russell Group universities 
accounted for 58% of those which had survived 
for three years.
   Of the 125 case studies the Russell Group collected 
separately from its member institutions, 66 included 
information about the ﬁ  nancial outcomes of research 
exploitation in the form of income generated from licencing 
or spin-out companies established within the last ten 
years. An analysis of these 66 case studies shows that:
 –    £1,090m was accrued in sales or licensing revenue
 –    24 spin-out companies had achieved a combined market 
value of £498m32 (where estimates of market value 
were available) 
“  It is not about the promise of future revenues that 
might be generated from this activity... Of course, 
revenue generation serves as an incentive. But fi  rst 
and foremost, technology transfer must serve our 
core mission: sharing ideas and innovations in 
the service of society’s well-being.”
      Dr Mary Sue Coleman, President, University of Michigan25
 –    a further 24 new spin out companies had secured 
commercial investment with a combined total of £330m.
   Together these examples represented a combined 
“value-added” to the economy of almost £2bn, 
a signiﬁ  cant ﬁ  nancial return on investment.
   An analysis of the distribution of ﬁ  nancial returns from 
the licensing and spin-out case studies from Russell 
Group universities shows a typical pattern: the majority 
of the income generated comes from a very small number 
of licences or spin-outs. Figure 3 above shows that just 
over 20% of the case studies accounted for over 80% 
of the ﬁ  nancial returns calculated. It also shows that the 
vast majority of the value returned over time originated 
from more fundamental, basic research.
   Although it may take many years to see direct commercial 
returns from research, beneﬁ  ts can arise during the 
development process. One of the clearest examples 
of this is the new job creation associated with university 
spin-out companies. The spin-out companies identiﬁ  ed 
in our case study data each generated on average 40 
additional, highly-skilled jobs.
   This analysis provides only a limited snapshot of direct 
economic impacts. All of the case studies featured 
will have signiﬁ  cant economic and other impacts which 
extend beyond the information a university will typically 
capture. For example, whilst the Edinburgh spin-out 
company MTEM (case study 20) generated $275m 
of direct revenue from its successful sale in 2007, the 
economic returns of the underpinning research extend 
far beyond this. As noted by Leon Walker, MTEM CEO:
  “  The economic impact of this technology has the 
potential to extend far beyond simply the value of the 
oil produced. By identifying new pockets of oil and gas, 
MTEM could extend the life of many oilﬁ  elds, increasing 
recovery rates also from the known reservoirs.”
   2.2 The impact of different subjects and 
multidisciplinary research
   An analysis of the IP licences and spin-out companies 
identiﬁ  ed from the Russell Group case studies by subject 
area (Figure 4) gives an indication of the areas of research 
from which the majority of this IP has sprung. Given that 
some disciplines lend themselves more than others to the 
generation of IP with commercial potential, it is not surprising 
that the majority of licences and spin-outs have been derived 
from medical research, the biological sciences, physical 
sciences, computer sciences, and engineering and technology.
   The number of licences and spin-outs which have originated 
within clinical and medical disciplines is noteworthy. The 
existence of a medical school with strong links to local 
hospitals and patient communities has previously been 
highlighted as an important determinant of successful 
university innovation.33 Approximately 80% of medical 
research in the higher education sector is within Russell 
Group institutions,34 and medical schools make a major 
contribution to achieving impact from research.
   Figure 4 also explores the range of different kinds of 
impact resulting from IP licensing and spin-out formation. 
This demonstrates a much broader spread of impacts 
than might be anticipated.
Figure 3: Distribution of financial returns from commercialised research at Russell Group universities
*“value” is intended as an indication of value added, drawn from a 
  combination of sales and licensing revenue, market valuation and 
 investments  made
RG case studies - skewed distribution of outcomes
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   A key feature of Russell Group universities is concentration 
of excellence. They have a large and high quality research 
staff, a critical mass of expertise and facilities and in most 
institutions a very wide range of academic disciplines. This 
strength and breadth enables Russell Group universities 
to support cutting-edge interdisciplinary research within 
and between institutions in the UK and internationally. 
It also provides a strong attractant for industrial partners 
and other users.
   Russell Group universities are home to many of the 
UK’s major interdisciplinary research centres such as 
the Warwick Innovative Manufacturing Research Centre, 
the Manchester Interdisciplinary Biocentre, and Institute 
of Biomedical Engineering at Imperial College.
Figure 4: Licences/spin-outs related to subject area
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   The ability to support and facilitate cutting-edge research 
across a broad range of disciplines generates an exchange 
of ideas and techniques which is a fertile source of 
innovation and advancement. It offers an opportunity 
to apply new perspectives to research challenges, 
propagating new lines of thought and investigation. 
Businesses are increasingly looking for interdisciplinary 
and multidisciplinary research as the source for future 
innovation35 and it is well recognised that multidisciplinary 
approaches are required to address major societal 
challenges such as sustainable energy generation 
and climate change.
   Case studies 20 and 21 provide good examples of the 
value of interdisciplinary research in underpinning the 
design of new products and techniques.27
Case study 20
MTEM
University of Edinburgh
A new technology to support deep-sea oil 
exploration
Key funding source: NERC/EU THERMIE
MTEM (Multi-transient Electromagnetic Technology), 
a spin-out company from the University of Edinburgh, 
developed a technology which allows the detection 
of hydrocarbons in deep underground reservoirs. 
Oil companies can use the technology to detect the 
presence of oil before drilling; potentially saving huge 
costs: it is estimated that more than a billion barrels 
of oil could be found using the technology.
MTEM stems from basic research conducted by 
Professor Anton Ziolkowski, in 1992, to test the 
fundamental principles behind the technique. After 
more than 11 years of further development, the 
company was founded in 2004.
MTEM’s technology has the potential to generate 
enormous economic returns, addressing an oil 
exploration market with an estimated value of 
around £500m.
In 2007, MTEM was sold to a Norwegian oil firm 
for $275m.
Case study 21
HeliSwirl
Imperial College London
Improving the efficiency of oil, gas and other 
fluid transport
Key Funding Source (development): the Carbon 
Trust, Imperial Innovations, business angels 
HeliSwirl provides a powerful example of the impact 
which can be achieved when multidisciplinary research 
creates new ideas, and applies them within new and 
unexpected fields.
The technology underpinning HeliSwirl was first 
developed within Imperial College’s department of 
Bioengineering: a department which describes itself 
as “inherently cross disciplinary” and where research 
“involves diverse academic disciplines such as physiology 
and medicine as well as mathematics, physics, 
chemistry and the different areas of engineering.” 
Over 40 years of research exploring the connection 
between arterial disease and blood-flow eventually led 
to a novel technology to improve the efficiency with 
which fluid flowed through pipes and other vessels. A 
patent was initially registered for a medical application. 
However, the management of HeliSwirl recognised 
that the new technology, called Small Amplitude 
Helical Technology (SMAHT) had the potential for 
much wider commercial application.
HeliSwirl’s primary focus is now directed towards 
engineering applications in the petrochemical, oil 
and gas industries, creating the potential for major 
reductions in energy use and greenhouse emissions 
associated with fluid transport. Thus far, the company 
has secured £1.4m in external investment.  PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
Case study 22
Critical Pharmaceuticals Ltd
University of Nottingham
A new technology to help drug delivery in 
vulnerable patients
Key funding source: various industry collaborations; 
EPSRC Adventure Fund
In 1999, Professor Steve Howdle, a researcher in the 
University of Nottingham’s Department of Chemistry, 
was conducting basic research into the properties 
of “supercritical” fluids; these are gases which, at a 
defined temperature, take on unique physical properties.
When he noticed that supercritical carbon dioxide 
(scC02) was able to penetrate certain polymers, 
he realised that it could be used to mix sensitive 
substances into the polymers.
Founded in 2002, Critical Pharmaceutical Ltd is 
a pioneering company which uses scC02 to mix 
drugs and other bioactive compounds with medically 
approved polymers, to allow controlled drug release in 
patients. This means, for example, that young patients 
with growth hormone deficiency can be saved the 
inconvenience of daily injections, or that doctors can 
better ensure that schizophrenia patients comply with 
their prescribed treatment. After more than five years 
of additional research, CPL realised its first commercial 
licence in 2004.
Thus, research into fundamental physical chemistry 
has created the potential for major impacts in 
healthcare. Although still in its early stages, the 
company has to date attracted inward investment 
in excess of £1.7m. 
   3.0 Enabling successful commercial exploitation 
of research
   Achieving signiﬁ  cant impacts from the commercial 
exploitation of research often involves long-term, strategic 
partnerships and collaborations with business and 
industry. As described in the ﬁ  rst part of this report, 
this could include the co-design, funding and production 
of basic or more applied research, joint sponsorship 
and training of doctoral students, networking activities 
with supply chain partners, consultancy, or continuing 
professional development, as well as licensing and 
patenting and the formation of spin-out companies. 
   In Russell Group institutions these activities are supported 
by teams of knowledge transfer professionals who work 
alongside academics to support and enable the commercial 
exploitation of their IP. This work is underpinned by 
institutional strategies, funding and processes aimed 
at enhancing effective knowledge transfer.
   All Russell Group institutions have dedicated technology 
transfer ofﬁ  ces (TTOs) or teams in order to commercialise 
new technology and ideas arising from their research. 
The Higher Education Innovation Fund (HEIF) in England 
(and the preceding funding streams HEROBC and 
University Challenge) and similar knowledge transfer 
funding streams in Scotland, Wales and Northern Ireland, 
have been crucial in supporting these developments. 
  “  We simply wouldn’t have been able to do it without 
(University of Manchester Technology Transfer 
Company) UMIP... setting up a company is a 
complicated process, and UMIP took care of it all”
  Dr Mary McGee, CEO, Assessment 21 Ltd
   The organisational structures and experience residing 
within university TTOs are essential to the institution’s 
overall success in realising returns on research and 
in disseminating its beneﬁ  ts to the wider economy: 
 –    the capacity of a TTO and its relationship to the parent 
university can signiﬁ  cantly impact on both its overall 
success rate in commercialising technology and on the 
preferred strategies by which technology is licensed 
to industry36, 37, 38
 –    policies on licensing revenue are strongly correlated 
to disclosure rates and licensing success39
 –    expenditure on IP protection and the business 
development capacity of a TTO is signiﬁ  cantly 
and positively correlated with spin-out formation40
 –    TTO size and the level of expertise it is able to draw 
on can be an important determinant of its success.4129
Case study 23
Intense
University of Glasgow
Laser technology for telecommunications, 
medicine and defence
Key funding source: EPSRC
“Intense” is a spin-out company formed in 1999 to 
commercialise high-power laser technology developed 
in the Department of Electronic and Electrical 
Engineering at the University of Glasgow.
The commercial technology was developed from 
underpinning basic research over a period of more 
than ten years. Intense manufactures state-of-the 
art laser diodes which it markets to the defence, 
telecommunications, medical and computing 
industries. The company now employs over 130 
people in Scotland and in the US, and has so far 
attracted over £48m in additional investment.
The expertise and long-term support provided by 
Glasgow’s Technology Transfer office was crucial 
to the success of Intense. TTO staff initially provided 
support in securing patent protection for the new 
technology. Their expertise subsequently enabled 
a market evaluation, and business support officers 
identified a product opportunity. In the subsequent 
development of the company, the TTO continued to 
provide essential underpinning support in business 
planning and securing external investment.
   The effectiveness of the TTO’s in Russell Group 
institutions is evident from the case studies. The vast 
majority of the licences granted and spin-outs established 
beneﬁ  ted from input from the institution’s in-house 
technology transfer capacity, which provided non-ﬁ  nancial 
input in the form of business development, marketing 
or IP protection. Case study 23 describes the formation 
of Intense, a spin-out company from the University of 
Glasgow and provides a typical example of the role 
of a TTO in achieving impact from research.
   Many of the case study examples also beneﬁ  ted from 
additional investment provided through Russell Group 
university Proof of Concept funding. Proof of Concept 
funding is an essential stage in the development of many 
emergent technologies from initial prototype to the stage 
where they are able to attract investment from venture 
capital ﬁ  rms or other commercial interest. The majority 
of innovations developed from Russell Group universities 
result from early stage, curiosity-driven research, and 
are at an embryonic stage of development at the time 
of disclosure to the TTO. Proof of Concept funding 
can therefore play an important role in bridging the gap 
between the initial research ﬁ  ndings and demonstrating 
potential commercial viability. This funding typically 
supports additional research and development or market 
research. The sums involved are often small (£10,000–
£30,000 would be typical), but there is generally thought 
to be a shortfall of funding available to universities for 
Proof of Concept support, which can be essential in helping 
to overcome the initial barriers to commercialisation and 
economic impact.
   The case studies collected from Russell Group institutions 
showed that:
 –    57% of projects had received Proof of Concept or seed 
funding during their early development
 –    of these, 62% were supported through by university 
funding (including institutional University Challenge 
funding)
 –    17% were supported by regional funds, of which half 
were funds provided by RDAs, and half were provided 
through the Scottish Enterprise Fund.
   Information about the use of Proof of Concept funding at 
the University of Shefﬁ  eld is highlighted in case study 24.PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
Case study 24
Proof of Concept funding 
The University of Sheffield
The University of Sheffield first established a 
Proof of Concept scheme in 2004, under the 
auspices of HEIF 2 funding. Its success was 
such that the scheme was extended under HEIF 3 
and will again be continued under HEIF 4.
The scheme awards funding up to a maximum of 
£10,000, to help innovative concepts developed 
by university staff with marketing, design, or further 
research. Thus far, a total of £603,000 has been 
awarded to 64 separate projects, resulting in five new 
spin-out companies, three new licence deals worth 
nearly £100,000, and over £9m in additional research 
grants, including contract research with industry.
The scheme has been a huge success with 
academics:
“The ‘Proof of Concept’ fund was an absolute 
godsend! It is a vitally important means of 
encouraging, promoting and creating IP and 
commercially orientated research. The scheme 
is extremely well administered by the University 
of Sheffield… The ‘Proof of Concept’ funding was 
absolutely essential in developing our IP portfolio 
and forming a company.”
Dr Jamal Nasir, Academic, University of Sheffield
“I wish to emphasise that, in my view, Proof of 
Concept funds are an essential resource for 
faculty to fully develop and secure their IP” 
Professor Steven Armes, Academic, 
University of Sheffield
   As well as employing knowledge transfer professionals, 
many research-intensive universities have established their 
own technology transfer companies to accelerate the 
exploitation of IP with commercial potential. 14 Russell 
Group universities have established such companies, 
and eight institutions have formed relationships with 
IP commercialisation companies to help exploit their IP.
   Nonetheless, relative to the size of their research output, 
there is room to develop signiﬁ  cant further capacity to 
support technology transfer and knowledge transfer.
   4.0 Economic impact case studies from Russell 
Group universities
   This ﬁ  nal section of the report showcases further examples 
of successful commercial exploitation from research 
undertaken at Russell Group universities.
  4.1 Economic impact from basic research
   Whilst the differentiation between basic and more applied 
research is becoming increasingly less relevant, we have 
undertaken an analysis of the 125 case studies collected 
from Russell Group universities using the standard 
Frascati deﬁ  nitions42 of research. This shows that basic,43 
curiosity-driven research has led to some of the most 
signiﬁ  cant returns to the UK economy and society arising 
from our case studies. Of the case studies submitted:
 –    57% were the result of basic research
 –    we were able to estimate ﬁ  nancial returns for 66 case 
studies. 74% of the total ﬁ  nancial return calculated was 
associated with commercial projects derived from basic 
research
 –    commercialisation of basic research generated average 
returns of £36m; more than twice the average return 
from applied research case studies
 –    the median ﬁ  nancial return from commercialisation 
of basic research was £8.7m – almost three times 
the median return from applied research case studies
 –    of the top ten projects, measured by ﬁ  nancial returns, 
eight were the product of basic research. (See ﬁ  gure 5)
   Figure 6 shows the relative proportion of licences and 
spin outs arising from our case studies which were based 
on basic and applied research respectively. It also shows 
the percentage of the ﬁ  nancial returns calculated which 
can be attributed to basic or applied research.
   The case studies below (25-32) all demonstrate the 
commercial potential released from basic research.31
Figure 5: Top ten case studies by research type
Distribution of ‘basic’ vs ‘applied’ research for 
the Top Ten Commercialisation case studies
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Figure 6: Relative proportions of case studies 
and of financial returns based on basic and 
applied research
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Case study 25
Renovo
University of Manchester
How alligator embryos advanced thinking on 
scar healing and wound reduction
Key funding source: research programme funded 
by a variety of sources, including MRC, BBSRC 
and EPSRC
Renovo, a University of Manchester spin-out company 
established to commercialise novel treatments for 
wound healing and scar reductions, is one of the 
largest university spin-out companies in the UK. 
Listed on the London Stock Exchange in April 2006, 
the company was valued at £348m in 2007. 
Research at Renovo has been directed at addressing 
the unmet medical need for pharmaceutical products 
to effectively aid wound healing and scar reduction. 
However, the basic science underpinning this research 
was discovered unexpectedly, by its co-founder, 
Mark Ferguson.
During the late 1980s, as a professor at Manchester, 
Mark conducted studies on alligators as part of his 
research into ways to correct cleft palates. He made 
the accidental discovery that, when working on 
alligator embryos, the incisions which he made healed 
without scarring. Over the course of 15 years, Mark 
and Renovo co-founder Sharon O’Kane worked on 
developing a synthetic formulation to mimic these 
healing properties. 
Renovo now employs 180 staff, and its lead product, 
Juvista, was recently licensed to SHIRE plc in a 
licensing deal worth up to $825m. PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
Case study 26
Avacta
University of Leeds
Advanced technology to support drug 
development and health screening
Key funding source: BBSRC/EPSRC
Avacta’s technology developed out of basic biotechnology 
research. Beginning in 1998, research by Professor 
Alastair Smith, Simon Webster and Kurt Baldwin at the 
University of Leeds led to the development of expertise 
in molecular detection technologies, which is now 
commercialised through Avacta.
The company was founded in 2004, after 6 years of 
underpinning research. Avacta’s molecular detection 
technologies are now at the forefront of drug invention; 
they are used by pharmaceutical companies, amongst 
others, in developing promising new therapies. The 
company’s expertise is also deployed to detect pathogens, 
such as dangerous viruses. This innovative detection 
technology has huge potential to be used in homeland 
security, as well as in screening for the protection of 
human health.  
As well as important healthcare benefits, the company 
has achieved considerable commercial success. It was 
listed on the Alternative Investment Market (AIM) branch 
of the London Stock Exchange in 2006, and expanded 
rapidly. It is currently valued at more than £23m.
Case study 27
Transitive Corporation
University of Manchester
Transitive Corporation was founded in 2000, to 
commercialise the outputs of basic computer science 
research at the University of Manchester.
The research underpinning Transitive resulted from 
problems encountered by an unrelated computer 
design project in 1992. Professor Alasdair 
Rawsthorne, the company founder, says that the 
research was begun in 1995 “purely for academic 
and personal reasons… Around two years into the 
research, I began to realise how important the 
technology could be.”
The technology which had been developed allowed 
for software applications to be easily translated across 
different computing systems: this allows software to 
be run on any computer platform without requiring 
changes to the software.
The technology has huge commercial potential. Transitive 
has already developed relationships with Apple 
and IBM, and have over 15m customers worldwide. 
The company has secured external investment to 
the value of US $30m.33
Case study 28
Cambridge Display Technologies 
and Plastic Logic
University of Cambridge
Building on fundamental physics research to 
develop a new generation of digital display 
technologies
Key funding source: EPSRC
In the early 1980s fundamental research by Professor 
Sir Richard Friend and Professor Andrew Holmes led to 
the unexpected discovery of organic electroluminescence 
from polymers, and the subsequent realisation that 
Light Emitting Diodes (LEDs) could be made from 
conjugated polymers.
Founded in 1992 on the basis of this discovery, 
Cambridge Display Technology is now the leading 
global manufacturer of technologies based on Polymer 
Light Emitting Diodes (PLEDs). Very efficient, and 
able to form ultra-thin lighting displays which operate 
at very low voltages, PLEDs are set to underpin the 
next generation of lighting displays and to replace 
liquid crystal displays (LCDs) and cathode ray tubes 
(CRTs) in many existing technologies, as well as 
opening up exciting possibilities for new product forms 
such as flexible or even wearable displays. CDT Ltd 
has so far raised over $170m through investments and 
sale of stock.
The research also led to another spin-out, Plastic Logic 
Ltd, whose revolutionary process for printing electronic 
circuits on flexible plastic substrates enables the 
manufacturing of light, flexible and robust electronic 
displays for electronic reading devices. The company 
currently employs a staff of 90, and has so far raised 
over $200m from venture capital funding in Europe, 
Asia and the US.
Case study 29
Bioluminescence
Cardiff University
Harnessing natural luminescence for medicine 
and diagnosis
Key Funding Source: MRC, EPSRC
Over 20 years of research into the way in which 
living creatures can generate their own natural lights 
or “bio-luminescence” enabled Professor Anthony 
Campbell and his colleagues at the University of Wales 
School of Medicine (now part of Cardiff University) 
to develop an important new tool for medical and 
health research.
Professor Campbell’s research throughout the 1970s 
and 1980s led him to the discovery that living creatures 
could produce light using special proteins called 
luciferases. He then realised that by combining these 
special proteins with other molecules, he could use 
the emission of light to measure important biological 
processes. The tools discovered by Professor Campbell 
are now used routinely in science and medicine, and 
have helped scientists to explore biology and disease 
– from the process of blood-clotting, to exploring how 
cells communicate with each other, to screening for 
potential new drugs.
In 1988, Molecular Light Technology Ltd was formed 
by Professor Campbell’s co-inventors, and in 2003, 
the company was acquired by Gen Probe Inc for $7.2m. 
As he points out: “It all started by me being curious 
about how animals that make their own light can 
produce a rainbow”. PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
Case study 30
NaturalMotion Ltd
University of Oxford
Developing ground-breaking software for the 
gaming industry
NaturalMotion Ltd, a spin-out company from 
the University of Oxford, was formed in order to 
commercialise research conducted by Torsten Reil 
and Colm Massey at the Department of Zoology.
The original research was targeted towards achieving 
a better understanding of the neural basis of animal 
and human motion. However, in designing new 
computer-based technology to gain further insight 
into this problem, the researchers created a novel 
IT application with enormous commercial potential.
NaturalMotion’s technology, Dynamic Motion Synthesis 
(DMS) uses artificial intelligence to simulate the human 
nervous system. Its euphoria product synthesises 3D 
character animation in real-time on the Playstation 3, 
Xbox 360 and PC: it has already been incorporated in 
blockbuster video games such as Grand Theft Auto IV, 
and Star Wars: the Force Unleashed. Another product, 
endorphin, is also widely used in the film and game 
industry.
Case study 31
Ceres Power
Imperial College London
Generating electricity efficiently within homes 
and offices
Key funding source: EPSRC
Ceres Power, a spin-out company from Imperial 
College London, is pioneering the field of efficient, 
low carbon power generation.
Building on over ten years of research at the 
university’s Department of Materials, Ceres Power 
is developing world leading fuel cell systems able to 
generate energy quietly and efficiently within office 
buildings and homes. Because this method is more 
efficient, and because the heat produced by electricity 
generation is also used to heat the building, fuel cells 
produce far fewer emissions than traditional forms 
of power generation.
Ceres Power builds on a portfolio of IP developed 
by a group of materials experts including Professor 
Brian Steele; Professor Nigel Brandon; Professor 
John Kilner; Professor Alan Atkinson and Bob Rudkin. 
Basic research into novel materials and catalysts 
underpinned a research programme that later 
demonstrated significant commercial potential.
Ceres Power is listed on the London Stock Exchange, 
and is currently valued at £73m (as at 12 January 
2009). The company employs 70 people, and in 
January 2008, Centrica (owner of British Gas) 
subscribed for 9.999% of the issued share capital 
of Ceres Power at 300p per share – equivalent to 
a cash investment of about £20m.35
Case study 32
Sucralose
King’s College London
Developing a zero-calorie sweetener
Key funding source: research collaboration with 
Tate & Lyle
The discovery of Sucralose has been described as 
perhaps being one of the strangest “accidental” research 
discoveries of all time. In 1978, researchers at King’s 
College London were investigating ways of using a 
chlorinated form of sucrose as a chemical intermediate. 
A graduate student was apparently asked to “test” 
the new compound, which he mistook for “taste”. 
On tasting it, he found that it was incredibly sweet.
Sucralose, a sucrose derivative many times sweeter 
than ordinary sugar, is now marketed by Tate & Lyle 
as Splenda: a zero calorie artificial sweetener. Splenda 
has generated enormous financial returns for Tate 
& Lyle, and unquestionably delivered wider benefits 
to the UK economy: last year, sales of Splenda were 
£148m. In addition, the product has improved the 
quality of many people’s lives, becoming an important 
ingredient in desserts and other sweet foods for 
diabetics, and in diet products.
Finally, an extended collaboration between Tate & Lyle 
and King’s College London has established the Tate & 
Lyle health research centre, which conducts research 
into gastrointestinal health, carbohydrate metabolism 
and related health implications such as obesity, diabetes 
and cardiovascular disorders.        
   4.2 Why sustained long-term investment is 
necessary to realise commercial potential
  “  The Internet? We’re not interested in it.”
Bill Gates 1993
   Many of the case studies showcased in this report highlight 
the long-term timescales and non-linear processes involved 
in the journey from research to commercial exploitation. 
For example, it took 12 years for the research begun by 
Professors Friend and Holmes to result in the formation 
of Cambridge Display Technologies (case study 28) and 
20 years for the formation of Plastic Logic. It was even 
longer before these companies were able to attract 
signiﬁ  cant commercial investment.
  Across all of the case studies collected: 
 –    the average timescale for a technology to progress 
from initial discovery to a ﬁ  rst licence was nine years
 –    the average commercialisation timescale for the top 
ten commercial successes (where ﬁ  nancial data was 
available) was more than ten years.
   Similar trends have been identiﬁ  ed in published literature 
on technology transfer.44
   There are two key factors which contribute to the 
development timescale of research impacts. The ﬁ  rst 
relates to the research itself, and the time-delays from its 
inception to the development of a commercially relevant 
idea. The second factor is the time-delay associated with 
bringing a commercially relevant idea to the market.
   It can take years to develop research to the 
point of commercial potential
   In many of the examples looked at in this document, the 
problems which the research set out to tackle were not 
ones with immediate commercial relevance, and it was 
only after years of underpinning research that commercial 
potential was revealed.
   Even where research sets out to explore an idea with 
obvious commercial potential, it may take many years 
of further investigation to develop the idea to the point 
where commercialisation is possible. For example, Solexa, 
one of the most successful companies spun-out from the 
University of Cambridge, was founded after researchers 
sought to develop a novel solution to DNA sequencing. 
The technology on which the company was eventually 
founded was directly related to the researchers’ initial 
goals, but it still took 11 years of research before their 
work was developed to the point that Solexa was formed 
(see case study 33). Through focused interactions with 
industry, universities can in some cases deliver important 
technological solutions rapidly and efﬁ  ciently. Yet their 
ability to do this invariably rests on the expertise developed 
through much longer-term, often fundamental, research 
(see case study 34). PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
Case study 33
Solexa
University of Cambridge
Spearheading DNA sequencing technology
Key funding source: BBSRC, Wellcome Trust, 
Abingworth LLP
Inspired by breakthrough “molecule watching” 
technology first described in 1994, Professor Shankar 
Balasubramanian and Professor David Klenerman 
decided to develop a joint research effort focused 
on DNA sequencing. They realised that, by combining 
their expertise in nucleic acids (the “building blocks” 
of DNA) and in molecular imaging, the potential was 
there to revolutionise DNA sequencing technology.
Early stage funding was secured from the BBSRC 
and the Wellcome Trust, and Proof-of-Concept funding 
from Abingworth (a life-sciences venture capital firm) 
followed. A patent was filed in 1998, but it took 
seven years of additional research before Solexa 
was eventually founded, in 2005.
In 2007, 13 years after the research began, Solexa 
was sold to bioscience company Ilumina for $600m. 
The technology has been used to sequence an entire 
human genome in just weeks. Understanding the 
human genome will be a vital tool in learning about 
how differences in people’s DNA can cause disease: 
as well as generating significant revenue for the 
University of Cambridge, the technology developed 
by Professors Balasubramanian and Klenerman could 
help scientists to understand and eventually to treat 
a huge number of illnesses. 
Case study 34
A new technique for repairing aero engines
University of Birmingham
Developing novel repair mechanisms to avoid 
costly component replacements
Key funding source: EPSRC/ERDF/Rolls Royce plc
A research collaboration between Rolls Royce plc and 
researchers at the University of Birmingham’s School 
of Metallurgy and Metals has resulted in a breakthrough 
new technology which is saving the company millions 
of pounds every year.
Researchers, led by Professor Xianhua Wu, were able 
to apply their dual expertise in metallurgy and new laser 
technology to develop a new means of repairing wear 
and tear in vital aero engine components by using 
lasers to apply a thin layer of the required metal alloys.
The technology means that Rolls Royce no longer need 
to replace the worn out components with entirely new 
ones, saving them millions of pounds. It has also had 
significant environmental benefits through reducing 
the company’s use of raw materials and the need 
for an energy-hungry manufacturing process.
The university’s researchers were well placed to deliver 
a rapid and efficient solution to the technological 
challenge which Rolls Royce presented, developing a 
major new technology within just three years. Yet the 
expertise which underpinned this work drew on over 
20 years of fundamental metallurgical science and 
advanced manufacturing research.37
   Time delays in bringing technologies to market
   Commercial licensing of a research idea can be a 
complex process, involving many steps, all of which can 
cause delay. A UK patent application, for example, takes 
an average of 18 months to process, and international 
patent applications can add a further 18 months, resulting 
in a possible three year delay simply to protect a new 
technology. The process of negotiating a technology 
licence can also be complex and involve long delays; 
often, further investigations must be carried out in order 
to demonstrate market potential or estimate the value 
of a new product. Similarly, the formation of a spin-out 
company to commercialise research is not achieved 
overnight; it requires market research and valuation, and 
early stage investment must be identiﬁ  ed and secured. 
The legal processes associated with company formation 
can in themselves be complex: the CEO of University 
of Manchester spin-out ﬁ  rm Myconostica Ltd estimated 
that it took a total of seven months to agree terms for 
the new company with the university and with investors. 
   Finally, developing a licensed technology to the point 
where it begins to generate commercial returns can 
often involve many years of additional work. In some 
cases, particularly where a new technology addresses 
challenges within an existing market, universities can 
successfully license their technology to a commercial 
partner. Since these technologies tend to be “near market” 
the commercial partner is more likely to be able to 
develop a marketable product within a short timescale, 
generating revenues for the university and returns to the 
economy. In cases where a spin-out company is formed 
to develop the new technology, however, the commercial 
opportunity tends to be much further from the market, 
and there may follow many further years of research 
and development to reach the stage where a marketable 
new technology is created, and returns on investment 
can be realised. 
   Analysis of the Russell Group case studies showed that 
it took on average a further 8.5 years after a licence was 
granted for revenue generation or in the case of spin-out 
companies a buy-out or exit. For these case studies, the 
timescale from research to ﬁ  rst realising a commercial 
return averaged over 17 years.
   In its Annual Review 2008, Cambridge Enterprises 
outlines the timeline of development for Plastic Logic, 
a breakthrough spin-out company with the potential to 
revolutionise the world of plastic electronics (see case 
study 28). The formation of Plastic Logic built on 15 years 
of fundamental physics research beginning in the 1980s. 
But as the timeline below shows, it took many years 
of further development and investment before the 
company’s products could be brought to the cusp 
of making a major commercial impact.45
Figure 7: Timeline for the commercial 
development of ‘Plastic Logic’46
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Fundamental Engineering & Physical Sciences Research Council 
funded research on the physics of semiconducting polymers 
for transistor applications in the laboratories of Professors 
Richard Friend and Henning Sirringhaus, Cavendish Laboratory, 
Department of Physics.
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Demonstration of organic transistor with performance 
comparable to that of thin film silicon.
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0
Demonstration of fully printed organic transistors.
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Company formed and first licence transferred from University 
to the company. The University Venture Fund invested in 
Cambridge Research and Innovation Limited (CRIL) which 
in turn provided seed funding for Plastic Logic.
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$18m funding round.
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$25m funding round.
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Building begins on factory located in Dresden, Germany.
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Headquarters moved to Mountain View, California; 
R&D in Cambridge, UK.
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Product demonstrated at DEMOfall 08 in the United States 
and awarded the DEMOgod People’s Choice. Official opening 
of the Plastic Logic factory in Dresden.
2
0
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0
Launch of the QUE proReader at the International Consumer 
Electronics Show.PART 2 – ACHIEVING ECONOMIC IMPACT THROUGH COMMERCIALISATION
   Long development timescales are particularly associated 
with new medical interventions, which can have profound 
effects on societies’ health and wellbeing, as well as 
generating more direct economic returns. A recent 
paper found that the median time-lag from discovery 
to demonstration of clinical efﬁ  cacy was 24 years.47
   There is clear evidence of this from within the Russell 
Group. For example, research conducted at Cardiff 
University in the 1980s led to a patented chemical 
process that was licensed to GE Healthcare (then 
Amersham) ﬁ  ve years later, but it wasn’t for another six 
years that GE Healthcare’s new diagnostic product, Myoview, 
was ﬁ  rst introduced to the US market. In another example, 
research conducted at Cambridge during the 1970s 
led to the development of a breakthrough technology 
in therapeutic monoclonal antibodies for leukaemia. 
Licensed as Campath in 1985, it wasn’t until 2007 that 
development by a series of pharmaceutical companies 
led to US Food and Drug Administration approval for 
Campath as a ﬁ  rst-line treatment for a type of chronic 
leukaemia. These examples illustrate how even once 
the commercial potential of research has been identiﬁ  ed 
through the licensing process, many years of development 
work are involved before a ﬁ  nal product or technology 
reaches the market and begins to deliver economic 
impact.
   4.3 Wider beneﬁ  ts and impact arising from 
commercialisation
   All of the case studies collected from Russell Group 
universities have demonstrated the potential of their 
underpinning research to beneﬁ  t society through endowing 
businesses with competitive advantage, bringing new 
consumer products to market, and often creating numerous 
job opportunities.
   However, we estimate that over 90% of the case studies 
also have the potential for delivering societal beneﬁ  ts 
as well, via better health care, cleaner and more efﬁ  cient 
energy sources or ‘quality of life’ beneﬁ  ts such as new 
entertainment, improved communication devices or 
other services.
   An analysis of the major areas where the research might 
be of beneﬁ  t to society is shown in ﬁ  gure 8.
 –    34% of the case studies have resulted or may result 
in a new treatment or diagnostic tool
 –    32% have resulted or may result in other healthcare 
impacts, such as new medical devices or research tools
 –    17% have the potential to generate signiﬁ  cant 
environmental beneﬁ  ts (for example through energy 
saving devices or reducing pollution)
 –    13% are associated with technologies which could 
improve people’s quality of life (through recreational or 
cultural activities, or added convenience to everyday life).
Figure 8: Achieving benefits for society
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   The following case studies illustrate very clearly how the 
commercial exploitation of research can lead to societal 
beneﬁ  ts and improvements in quality of life, as well 
as economic beneﬁ  ts. A further way in which research 
can have a signiﬁ  cant impact on society is through its 
inﬂ  uence on government and policy development. This is 
an area we intend to explore more fully in a subsequent 
report looking at the impact of Russell Group research 
on policy.39
Case study 35
Oxford Catalysts Group plc
University of Oxford
Novel technologies to develop clean fuel and 
low-carbon energy
Key funding source: various multinational oil, gas 
and energy companies
Oxford Catalysts Group is a University of Oxford 
spin-out company, formed to commercialise research 
originating in the Department of Chemistry. Based on 
over 18 years of research by Professor Malcolm Green 
and his more recent partnership with Dr Tiancun Xiao, 
the company markets technology based on a number 
of novel catalysts for generating clean fuels.
The company recently floated on the Alternative 
Investment Market (AIM) branch of the London Stock 
Exchange, with an initial market valuation of $50m.
In addition to its significant financial return, however, 
the company has the potential to create real 
environmental benefits in the area of energy and fuel 
production. The catalysts which it markets have broad 
ranging application, including removal of sulphur from 
crude oil fractions, generating virtually sulphur free 
liquid fuel from natural gas, coal or biomass, and 
converting biogas into syngas in order to generate 
liquid fuel.
Another innovative application of the technology 
is the generation of instant steam, at temperatures 
ranging from 100–600 degrees centigrade, which 
has the potential to serve as a source of green energy 
in the form of motive power or electricity.
Case study 36
Arrow Therapeutics Ltd
University College London
Improving our understanding of viruses to help 
develop new medicines
Based on research at University College London, 
Arrow therapeutics has developed an array of 
potential candidates for novel anti-viral drugs. Basic 
research by Professor Ian Charles into molecular 
pathogenicity led to the creation of a novel technology 
termed Transposon-mediated Differential Hybridisation 
(TMDH), which allows researchers to analyse the 
genes of a target organism.
Arrow therapeutics was purchased by Astra Zeneca 
in 2007 for around $150m in cash, generating large 
financial returns for the researchers and the university. 
The products being developed by the company work 
to combat important pathogens such as Hepatitis C 
and Respiratory Syncytial Virus (RSV): they could 
therefore have enormous impacts on healthcare, 
and potentially save many lives.  Approach
   In 2008 representatives from Russell Group institutions 
were asked to submit case studies where signiﬁ  cant 
impacts had been achieved as a result of the commercial 
exploitation of their research and IP. Institutions were 
encouraged to include examples which had both ﬁ  nancial 
and non-ﬁ  nancial signiﬁ  cance and impact.
   Each institution was invited to submit up to ten case 
studies taken from the last decade (1998 to 2008), 
although encouragement was given to focus on more 
recent examples which have utilised the expansion of 
university technology transfer capacity, largely funded 
through HEIF. However, as one of the aims of the 
exercise was to identify interesting and informative 
case studies, we accepted some case studies which 
pre-dated the ten year period originally speciﬁ  ed.
   Institutions were given a template for use as a guide 
when submitting case studies. For each case study, 
they were asked to provide:
 –    a description of the new knowledge, technology 
or innovation
 –    information about the research which had led to it
 –    information about timescales from research 
commencing to a licence being granted and/or spin 
out company formed, and where relevant to commercial 
application
 –    a description of the impact including a “value” estimate 
based on ﬁ  nancial outcomes where ﬁ  nancial data was 
available.
 Response
   A total of 125 case studies were collected from 
17 institutions.
   36 case studies related to commercial licences.
   78 case studies related to spin-out companies.
   The largest number of case studies received from a single 
institution was 13, and the smallest 3. The date of licence 
or spin-out formation ranged from 1978-2007.
 Analysis
   Whilst the data provided in the case studies do not lend 
themselves to statistical analysis, it possible to undertake 
some broad analysis and categorisation of the information 
provided. Each case study was appraised to identify:
 –    the nature of the research which underpinned it 
(basic/strategic basic/applied)
 –    the major source(s) of funding for the research and, 
where possible, development activities
 –    the support provided by the university Technology Transfer 
Ofﬁ  ce (TTO), including Proof of Concept funding 
 –    the number of years to progress from research inception 
to licence or spin-out formation 
 –    the “value” generated by the project, where this could 
be readily quantiﬁ  ed in terms of direct ﬁ  nancial returns
 –    “societal” impact: where the project clearly had potential 
to impact on healthcare, the environment, quality of life 
or other clear beneﬁ  ts to society
 –    research area (by JACS principal subject area).
   Where information about ﬁ  nancial returns was available 
this was aggregated to provide an indicative ﬁ  gure of 
“value-added”, recognising that the estimated value of 
the ﬁ  nancial returns depended largely on how far the work 
had progressed. For some case studies institutions were 
able to provide a ﬁ  gure for overall revenues generated 
– from licensing revenue or sale of equity – while others 
provided a ﬁ  gure for spin-out company valuation or external 
investment accrued. 
   Where possible, the information used was total sales/
licensing income, rather than income accruing to the 
university, in order to provide a clearer estimation of “value- 
added” to the UK economy. In all cases efforts have been 
made to avoid double counting of returns and over-weighting 
those cases for which more detailed information is available.
   The market valuation of spin-out companies is subject to 
ﬂ  uctuation, and this is likely to have been particularly marked 
during the recent economic downturn. We have used – both 
in the case studies and the overall statistics – the most up 
to date information that was available, but this may differ 
signiﬁ  cantly from present day values for some companies.
APPENDIX A
  Methodology used in collecting and analysing 
Russell Group case studies of commercialisation41
 Key  results
   56% of cases in this data set were classed as resulting 
from basic research, while 43% were classed as resulting 
from applied research.48
   An estimate of ﬁ  nancial value generated was ascertained 
for 66 case studies.
   Of these 66, the total ﬁ  nancial returns generated were 
estimated at £1.99bn.
   Of the 66 case studies, 38 were classed as resulting 
from basic research, representing a total ﬁ  nancial value 
of £1.5bn; 28 were classed as resulting from applied 
research, representing a total ﬁ  nancial value of £0.5bn.
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